Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 Dec;20(6):834–836. doi: 10.1128/aac.20.6.834

Activity of Di-β-Lysyl-Capreomycin IIA and Palmitoyl Tuberactinamine N Against Drug-Resistant Mutants with Altered Ribosomes

Takeshi Yamada 1, Tadashi Teshima 2, Tetsuo Shiba 2
PMCID: PMC181807  PMID: 6173016

Abstract

The effects of 61 synthetic tuberactinomycin derivatives on polypeptide synthesis were tested in bacterial cell-free systems. Di-β-lys-capreomycin IIA was more effective than the natural product. Palmitoyl tuberactinamine N inhibited the growth of tuberactinomycin-resistant mutants and was not a ribosome inhibitor.

Full text

PDF
834

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davies J., Gorini L., Davis B. D. Misreading of RNA codewords induced by aminoglycoside antibiotics. Mol Pharmacol. 1965 Jul;1(1):93–106. [PubMed] [Google Scholar]
  2. Liou Y. F., Tanaka N. Dual actions of viomycin on the ribosomal functions. Biochem Biophys Res Commun. 1976 Jul 26;71(2):477–483. doi: 10.1016/0006-291x(76)90812-3. [DOI] [PubMed] [Google Scholar]
  3. Mizuguchi Y., Suga K., Masuda K., Yamada T. Genetic and biochemical studies on drug-resistant mutants in Mycobacterium smegmatis. Jpn J Microbiol. 1974 Nov;18(6):457–462. doi: 10.1111/j.1348-0421.1974.tb00834.x. [DOI] [PubMed] [Google Scholar]
  4. Modolell J., Vázquez The inhibition of ribosomal translocation by viomycin. Eur J Biochem. 1977 Dec;81(3):491–497. doi: 10.1111/j.1432-1033.1977.tb11974.x. [DOI] [PubMed] [Google Scholar]
  5. Noda T., Take T., Nagata A., Wakamiya T., Shiba T. Chemical studies on tuberactinomycin. 3. The chemical structure of viomycin (tuberactinomycin B). J Antibiot (Tokyo) 1972 Jul;25(7):427–428. doi: 10.7164/antibiotics.25.427. [DOI] [PubMed] [Google Scholar]
  6. Nomoto S., Shiba T. Chemical studies on tuberactinomycin. XIII. Modification of beta-ureidodehydroalanine residue in tuberactinomycin N. J Antibiot (Tokyo) 1977 Nov;30(11):1008–1011. doi: 10.7164/antibiotics.30.1008. [DOI] [PubMed] [Google Scholar]
  7. Nomoto S., Teshima T., Wakamiya T., Shiba T. The revised structure of capreomycin. J Antibiot (Tokyo) 1977 Nov;30(11):955–959. doi: 10.7164/antibiotics.30.955. [DOI] [PubMed] [Google Scholar]
  8. Shiba T., Ando T., Teshima T. Chemical studies on tuberactinomycin. XVI. Synthesis of tuberactinomycin N. J Antibiot (Tokyo) 1979 Oct;32(10):1078–1079. doi: 10.7164/antibiotics.32.1078. [DOI] [PubMed] [Google Scholar]
  9. Suga K., Mizuguchi Y. Mapping of antibiotic resistance markers in Mycobacterium smegmatis. Jpn J Microbiol. 1974 Mar;18(2):139–147. doi: 10.1111/j.1348-0421.1974.tb00802.x. [DOI] [PubMed] [Google Scholar]
  10. Tanaka N., Igusa S. Effects of viomycin and polymyxin B on protein synthesis in vitro. J Antibiot (Tokyo) 1968 Mar;21(3):239–240. doi: 10.7164/antibiotics.21.239. [DOI] [PubMed] [Google Scholar]
  11. Teshima T., Nomoto S., Wakamiya T., Shiba T. Chemical studies on tuberactinomycin. XV. Total synthesis of tuberactinomycin O. J Antibiot (Tokyo) 1977 Dec;30(12):1073–1079. doi: 10.7164/antibiotics.30.1073. [DOI] [PubMed] [Google Scholar]
  12. Yamada T., Bierhaus K. H. Viomycin favours the formation of 70S ribosome couples. Mol Gen Genet. 1978 May 31;161(3):261–265. doi: 10.1007/BF00330999. [DOI] [PubMed] [Google Scholar]
  13. Yamada T., Masuda K., Mizuguchi Y., Suga K. Altered ribosomes in antibiotic-resistant mutants of Mycobacterium smegmatis. Antimicrob Agents Chemother. 1976 May;9(5):817–823. doi: 10.1128/aac.9.5.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Yamada T., Masuda K., Shoji K., Hori M. Analysis of ribosomes from viomycin-sensitive and -resistant strains of Mycobacterium smegmatis. J Bacteriol. 1972 Oct;112(1):1–6. doi: 10.1128/jb.112.1.1-6.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Yamada T., Mizugichi Y., Nierhaus K. H., Wittmann H. G. Resistance to viomycin conferred by RNA of either ribosomal subunit. Nature. 1978 Oct 5;275(5679):460–461. doi: 10.1038/275460a0. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES